WebmailIPPIS |DTWMS                           

Dr. CLET NIYIKIZA

Position: 
COUNCILLOR

 

Dr. Clet Niyikiza is the Founder, President and CEO of L.E.A.F. Pharmaceuticals LLC, after serving as the Executive Vice President of Development at Merrimack Pharmaceuticals, Inc. from 2009 until 2014 where he was involved in the development and approval of ONIVYDE®, for the treatment of advanced pancreatic cancer. Dr. Niyikiza also served from 2005 to 2009 as a Vice President and Medicine Development Leader at GlaxoSmithKline where he oversaw global anti-cancer assets medicine development strategy. Prior to that, Dr. Niyikiza joined the pharmaceutical industry in January 1991 with Syntex Corporation (since acquired by Roche Holding AG), in Palo Alto, California, working on the discovery and development of the pain medication, ALEVE®. He then held multiple high level positions at Eli Lilly from 1993 to 2005. He is a member of the American Association for Cancer Research and the American Society of Clinical Oncology. Dr. Niyikiza holds a doctorate in Mathematics from Indiana University-Bloomington, Indiana, U.S.A., and is currently a member of the Presidential Advisory Council of Rwanda. Prof. Niyikiza is also a member of the board of governors of the National University of Rwanda.

About NCST

Our core mission is to provide strategic advices and recommendations to the Government on all matters relating to policies, legislation and regulation in the fields of science, technology, research and innovation and monitor the implementation of such policies and legislation. It also mandated to mobilise the National Research and Innovation Fund to facilitate Researchers and Innovators

Useful links

Access NCST E-mail account
Document Tracking
Sign up to our newsletter:

Get in touch

National Council for Science and Technology (NCST)
13th Floor, Grand Pension Plaza
KN 2 Avenue, Nyarugenge - Kigali - Rwanda
P.O. Box 2285 Kigali

contact@ncst.gov.rw

http://ncst.gov.rw